Great Lakes Clinical Trials is pleased to announce the recent expansion of its peripheral blood mononuclear cells (PBMC) laboratory. Located on the north-side of Chicago, Great Lakes Clinical Trials’ PBMC lab is private, independent and truly full-service.
“Over the past 2 years, the Great Lakes Clinical Trials team has collected and isolated thousands of PBMC samples,” commented Steve Satek, President snd CEO. “We recently made a significant investment to expand our services to include PBMC cell counting and long-term Liquid Nitrogen storage.”
Human peripheral blood mononuclear cells (PBMCs) are key components of the body’s complex and dynamic immune system. A mononuclear cell is characterized by a single round nucleus and includes lymphocytes, monocytes, and dendritic cells. These cells have important immunological roles defending the body from infection, cancer, and other foreign invaders, making them ideal specimens to study immunological responses.
This full-service offering of Great Lakes Clinical Trials’ PBMC lab is a perfect, seamless supplement to the clinical trial programs being conducted at the various Great Lakes Clinical Trials clinics, particularly in regard to our numerous vaccine clinical trials. “Clinical trial sponsors can now come to Great Lakes Clinical Trials, not only to run the medical aspect of their vaccine studies,” added Satek, “but they can have the same facility process, count and store PBMC samples for future analysis. This creates a seamless service offering in an independent, private setting that is unique to the Chicago area.”
Note that Great Lakes Clinical Trials’ PBMC lab in Chicago is also able to serve as an external, local laboratory for processing of samples collected from other research clinics in the Chicagoland region.
For more information on Great Lakes Clinical Trials PBMC lab and to learn how to contact our team directly, please visit our PBMC webpage by clicking the button below: